PL382307A1 - Sposób przygotowania farmaceutycznej kompozycji w postaci szybko dyspersyjnej dawki i stała, doustna, szybko dyspersyjna postać dawki - Google Patents

Sposób przygotowania farmaceutycznej kompozycji w postaci szybko dyspersyjnej dawki i stała, doustna, szybko dyspersyjna postać dawki

Info

Publication number
PL382307A1
PL382307A1 PL382307A PL38230705A PL382307A1 PL 382307 A1 PL382307 A1 PL 382307A1 PL 382307 A PL382307 A PL 382307A PL 38230705 A PL38230705 A PL 38230705A PL 382307 A1 PL382307 A1 PL 382307A1
Authority
PL
Poland
Prior art keywords
dispersive
oral
dosage
dose
quickly
Prior art date
Application number
PL382307A
Other languages
English (en)
Other versions
PL218958B1 (pl
Inventor
Desmond Yik Teng Wong
Andrzej Jan Brzozowski
Leon Paul Grother
Original Assignee
R.P. Scherer Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R.P. Scherer Technologies, Inc. filed Critical R.P. Scherer Technologies, Inc.
Publication of PL382307A1 publication Critical patent/PL382307A1/pl
Publication of PL218958B1 publication Critical patent/PL218958B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL382307A 2004-06-03 2005-06-03 Sposób wytwarzania farmaceutycznej kompozycji w postaci szybko dyspergującej dawki i stała, doustna, szybko dyspergująca postać dawki PL218958B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/860,106 US7972621B2 (en) 2004-06-03 2004-06-03 Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Publications (2)

Publication Number Publication Date
PL382307A1 true PL382307A1 (pl) 2007-08-20
PL218958B1 PL218958B1 (pl) 2015-02-27

Family

ID=35449231

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05758824T PL1765299T3 (pl) 2004-06-03 2005-06-03 Sposób formułowania szybko dyspergujących postaci dawkowania, zawierających co najmniej jedną rybią żelatynę wybraną na podstawie masy cząsteczkowej
PL382307A PL218958B1 (pl) 2004-06-03 2005-06-03 Sposób wytwarzania farmaceutycznej kompozycji w postaci szybko dyspergującej dawki i stała, doustna, szybko dyspergująca postać dawki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL05758824T PL1765299T3 (pl) 2004-06-03 2005-06-03 Sposób formułowania szybko dyspergujących postaci dawkowania, zawierających co najmniej jedną rybią żelatynę wybraną na podstawie masy cząsteczkowej

Country Status (19)

Country Link
US (1) US7972621B2 (pl)
EP (1) EP1765299B1 (pl)
JP (1) JP5144258B2 (pl)
KR (1) KR101161430B1 (pl)
CN (2) CN1960710A (pl)
AU (1) AU2005251773B2 (pl)
BR (1) BRPI0511067B8 (pl)
CA (1) CA2567830C (pl)
DK (1) DK1765299T3 (pl)
ES (1) ES2654293T3 (pl)
HU (1) HU230429B1 (pl)
IL (1) IL179777A (pl)
IS (1) IS8588A (pl)
MX (1) MXPA06013921A (pl)
NO (1) NO342135B1 (pl)
PL (2) PL1765299T3 (pl)
RU (1) RU2415665C2 (pl)
WO (1) WO2005120464A1 (pl)
ZA (1) ZA200610664B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
NZ563911A (en) 2005-05-19 2011-11-25 Aqua Bio Technology Asa Gelatin-containing topical composition
DE102006033168A1 (de) * 2006-07-10 2008-01-17 Gelita Ag Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung
BRPI0908539B8 (pt) * 2008-02-28 2021-05-25 Scherer Technologies Llc R P processo para a preparação de uma forma sólida rápida de dosagem da dispersão, oral de alprazolam
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
HUE052853T2 (hu) * 2010-10-08 2021-05-28 Scherer Technologies Llc R P Orális vakcina gyorsan oldódó dózisforma, keményítõ alkalmazásával
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US20240000705A1 (en) * 2020-09-17 2024-01-04 Catalent U.K. Swindon Zydis Limited Use of surfactant with high molecular weight fish gelatin based dosage formulations to improve flow characteristics
WO2022074127A2 (en) * 2020-10-08 2022-04-14 Catalent U.K. Swindon Zydis Limited Stable oral dispersible formulation for epinephrine and salts or solvates thereof
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022103639A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs
IL309143A (en) * 2021-06-11 2024-02-01 Orphai Therapeutics Inc Stabilized apilimod compositions and uses thereof
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
US4767789A (en) * 1986-10-21 1988-08-30 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5039540A (en) * 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
EP0622413B1 (en) 1992-11-11 2002-02-27 Toray Industries, Inc. Polyester films for magnetic recording media
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
ES2234010T3 (es) * 1996-04-12 2005-06-16 Novadel Pharma Inc. Aerosol bucal polar.
US6258380B1 (en) * 1999-03-05 2001-07-10 Banner Pharmacaps, Inc. Chewable soft capsule
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US6709699B2 (en) * 2000-09-27 2004-03-23 Kabushiki Kaisha Toshiba Film-forming method, film-forming apparatus and liquid film drying apparatus
US6706669B2 (en) * 2001-07-13 2004-03-16 Exxonmobil Research And Engineering Company Method for inhibiting corrosion using phosphorous acid
HRP20041152B1 (hr) * 2002-05-07 2008-01-31 Ferring B.V. Farmaceutske formulacije
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
GB2388776B (en) * 2002-05-21 2004-08-25 Croda Int Plc Succinylated fish gelatin for use as a blood plasma expander
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives

Also Published As

Publication number Publication date
HU230429B1 (hu) 2016-06-28
BRPI0511067B8 (pt) 2021-05-25
RU2006147244A (ru) 2008-07-20
IS8588A (is) 2006-12-28
JP2008501709A (ja) 2008-01-24
CA2567830A1 (en) 2005-12-22
CN1960710A (zh) 2007-05-09
KR101161430B1 (ko) 2012-07-02
IL179777A0 (en) 2007-05-15
EP1765299A1 (en) 2007-03-28
AU2005251773B2 (en) 2010-12-16
NO342135B1 (no) 2018-03-26
EP1765299A4 (en) 2011-03-09
EP1765299B1 (en) 2017-11-15
BRPI0511067A (pt) 2007-12-26
CA2567830C (en) 2013-08-13
CN102172345A (zh) 2011-09-07
AU2005251773A1 (en) 2005-12-22
US20050271719A1 (en) 2005-12-08
HUP0700043A2 (en) 2009-03-02
RU2415665C2 (ru) 2011-04-10
KR20070039524A (ko) 2007-04-12
NO20066070L (no) 2007-02-27
WO2005120464A1 (en) 2005-12-22
BRPI0511067B1 (pt) 2018-11-06
US7972621B2 (en) 2011-07-05
IL179777A (en) 2015-09-24
JP5144258B2 (ja) 2013-02-13
DK1765299T3 (en) 2018-01-22
CN102172345B (zh) 2018-05-04
PL218958B1 (pl) 2015-02-27
ES2654293T3 (es) 2018-02-13
MXPA06013921A (es) 2007-01-26
PL1765299T3 (pl) 2018-05-30
ZA200610664B (en) 2007-12-27
HUP0700043A3 (en) 2012-09-28

Similar Documents

Publication Publication Date Title
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
PL382307A1 (pl) Sposób przygotowania farmaceutycznej kompozycji w postaci szybko dyspersyjnej dawki i stała, doustna, szybko dyspersyjna postać dawki
IL181734A (en) Surapnib Tosylate Polymorph, Pharmaceuticals Containing It and Using It to Make Medicines
IL184065A (en) Tetrahydroquinoline analogs, their use in the preparation of pharmaceuticals and pharmaceutical compositions containing them
IL213597A0 (en) Compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL171683A (en) Immunosuppressive Compounds, Medicinal Products Containing Them and Their Use in the Preparation of Medication for Treatment
IL193762A (en) The effective compounds in inhibiting dgat1-related disorders, their medicinal products and their use in the preparation of drugs
IL177283A (en) Pyrazolopyrimidine compounds, their use in the preparation of medicines and pharmaceuticals containing them
IL181524A (en) Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs
IL181382A0 (en) Time-limited release type granular pharmaceutical composition for oral administration and intraoral rapid disintegration tablet containing the composition
TWI367096B (en) Vitamin-receptor binding drug delivery conjugates and pharmaceutical compositions
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
IL236426B (en) Use of a compound in combination with bortezomib to prepare a drug for a neoplastic disease and a pharmaceutical preparation containing a compound and bortezomib
IL183974A (en) Derivatives of 5h - Benzocycloheptane Tetralin and Indane, medicinal preparations containing them, and their use in the preparation of medicines
IL220759A (en) Compounds 5,3-bi-canned and 7,5,3 three-canned-3 h- oxazolo and 3 h- thiazolo [d-5,4 [pyrimidine-2-one, pharmaceuticals containing them containing them and their use in the preparation of medicines
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL174647A (en) Pyrazolopyridines and analogs thereof, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
SI2046298T1 (sl) Farmacevtska odmerna oblika, ki vsebuje farmacevtsko sprejemljiv solubilizirni sestavek
IL163894A (en) 2-hydroxy-3-heteroarylindole derivatives, pharmaceutical compositions comprising them and their uses in the preparation of medicaments
IL183928A0 (en) Bcma polypeptides, their preparation and pharmaceutical compositions containing them
IL188744A0 (en) High drug load formulations and dosage forms
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL201730A (en) History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs
IL180899A0 (en) Pharmaceutical composition comprising drospirenone and ethynylestradiol